Surabhi Gautam, Romsha Kumar, Uma Kumar, Sanjeev Kumar, Kalpana Luthra, Rima Dada
Journal: Scientific reports 2023;13(1):14924
PMID: 37696876
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease of multifactorial origin that develops due to unfavourable coincidence of genetic, immune, and environmental factors. The pathogenesis of RA is heavily influenced by immune cells, particularly B-cells, T-cells, and macrophages. The aim of this study was to investigate the impact of yoga on modulation of the T-cell subsets, T-cell ageing markers, epigenetic alterations and associated transcription factors in RA. This study was an investigator blinded randomised controlled trial. Participants (n=64) were randomised into 2 groups (each group n=32) - the yoga group and non-yoga group. Results showed that 8 weeks of yoga practice significantly reduced disease activity, normalised the biomarkers associated with inflammation, and maintained T17/Treg cell [T helper 17 cells (T17) are a subset of pro-inflammatory T helper cells defined by their production of interleukin 17 (IL-17)] homeostasis. Furthermore, yoga reduced the rate of immunological ageing. Authors concluded that the impact of regular practice of yoga was beneficial as there was a significant reduction in the systemic levels of pro-inflammatory markers (IL-6 and IL-17) and various transcripts associated with pro-inflammatory cytokines. Hence, yoga can be used as an adjuvant therapy in RA as it boosts physical functioning, enhances psychological wellbeing and re-establishes immunological tolerance.
The pathogenesis of rheumatoid arthritis (RA) is characterized by a Th17/Treg cell imbalance. A pro-inflammatory cytokine milieu that promotes the continued proliferation of Th17 cells is related to the development of autoinflammation. In RA, T cells have several hallmarks of cellular aging, and they accumulate DNA damage, predisposing to the occurrence of mutations and epigenetic alterations. Since the onset, progression, and treatment response are influenced by a variety of external stressors and environmental factors, this study aimed to evaluate the impact of 8-week yoga practice on disease severity, T cell subsets, markers of T cell ageing and inflammation, epigenetic alterations and gene expression patterns in active RA patients on standard disease-modifying anti-rheumatic drugs (DMARDs). A total of 64 participants with active RA were randomized into 2 groups, yoga group (n = 32) or non-yoga group (n = 32); that were assessed for disease severity, at baseline and after 8 week duration, for Disease Activity Score (DAS28-ESR), T cell subsets [Th17 (CD3+ CD4+ IL17+ RORγt+) cells and Treg (CD3+ CD4+ CD25+ CD127-Foxp3+) cells], markers of T cell aging [aged Th17 cells (CD3+ CD4+ IL17+ RORγt+ CD28-) and aged Treg cells (CD3+ CD4+ CD25+ CD127-Foxp3+ CD28-)], pro-inflammatory markers [IL-6, and IL-17], anti-inflammatory markers [TGF-β, and IL-10], epigenetic alterations [5-methyl cytosine, 5-hydroxymethyl cytosine, and HDAC1] and gene expression patterns [RORγt, FoxP3, IL-17, IL-6, TGF-β, CXCL2, CXCR2, and JUN]. In yoga group, there was a significant improvement in DAS28-ESR scores at the end of 8-weeks of yoga program. The Th17 cells and aged T cell subsets showed a significant decline whereas Treg cell population showed a significant elevation in yoga group. There were significant improvements observed in epigenetic markers as well as inflammatory markers post 8-weeks of yoga practice. The yoga group showed downregulation of RORγt, IL-17, IL-6, CXCL2, CXCR2, and upregulation of FoxP3 and TGF-β transcripts. Yoga enables the maintenance of immune-homeostasis as evident by increased Treg cell population and reduced Th17 cell population. Yoga reduces the rate of immunological aging in T cells, as seen by the reduction in population of aged Th17 cells and aged Treg cells. Yoga positively modifies transcriptome and epigenome by normalization of various inflammatory markers, gene expression patterns and epigenetic alterations. Taken together, yoga reduces RA severity, and aids in immune-modulation and hence can be beneficial as an adjunct therapy.
© 2023. Springer Nature Limited.
Full Text Sources:
Medical:
Miscellaneous:
Research Materials:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.